![Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial - The Lancet Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/aee18a25-2db9-4bae-83e7-34231c19f7e4/gr1_lrg.gif)
Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial - The Lancet
![Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses - ScienceDirect Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2666379120302445-fx1.jpg)
Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses - ScienceDirect
![Cells | Free Full-Text | Heterologous Immunity between Adenoviruses and Hepatitis C Virus (HCV): Recombinant Adenovirus Vaccine Vectors Containing Antigens from Unrelated Pathogens Induce Cross-Reactive Immunity Against HCV Antigens Cells | Free Full-Text | Heterologous Immunity between Adenoviruses and Hepatitis C Virus (HCV): Recombinant Adenovirus Vaccine Vectors Containing Antigens from Unrelated Pathogens Induce Cross-Reactive Immunity Against HCV Antigens](https://pub.mdpi-res.com/cells/cells-08-00507/article_deploy/html/images/cells-08-00507-ag-550.jpg?1571589884)
Cells | Free Full-Text | Heterologous Immunity between Adenoviruses and Hepatitis C Virus (HCV): Recombinant Adenovirus Vaccine Vectors Containing Antigens from Unrelated Pathogens Induce Cross-Reactive Immunity Against HCV Antigens
![The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses | Nature Reviews Immunology The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses | Nature Reviews Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41577-022-00809-x/MediaObjects/41577_2022_809_Fig1_HTML.png)
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses | Nature Reviews Immunology
![Is preexisting immunity to seasonal coronaviruses limited to cross- reactivity with SARS-CoV-2? A seroprevalence cross-sectional study in north-eastern France - eBioMedicine Is preexisting immunity to seasonal coronaviruses limited to cross- reactivity with SARS-CoV-2? A seroprevalence cross-sectional study in north-eastern France - eBioMedicine](https://www.thelancet.com/cms/attachment/86769381-94ba-420c-91c9-6c2bb6aa8800/gr1_lrg.jpg)
Is preexisting immunity to seasonal coronaviruses limited to cross- reactivity with SARS-CoV-2? A seroprevalence cross-sectional study in north-eastern France - eBioMedicine
Mechanism of Antigen Presentation and Specificity of Antibody Cross- Reactivity Elicited by an Oligosaccharide-Conjugate Cancer Vaccine | Journal of the American Chemical Society
![Manipulating the Selection Forces during Affinity Maturation to Generate Cross-Reactive HIV Antibodies: Cell Manipulating the Selection Forces during Affinity Maturation to Generate Cross-Reactive HIV Antibodies: Cell](https://www.cell.com/cms/attachment/6a0af54d-bb65-4cec-aab5-94dd217872dd/fx1_lrg.jpg)
Manipulating the Selection Forces during Affinity Maturation to Generate Cross-Reactive HIV Antibodies: Cell
Minimizing antibody cross-reactivity in multiplex detection of biomarkers in paper-based point-of-care assays - Nanoscale (RSC Publishing)
![IJMS | Free Full-Text | Unsolved Puzzles Surrounding HCV Immunity: Heterologous Immunity Adds Another Dimension IJMS | Free Full-Text | Unsolved Puzzles Surrounding HCV Immunity: Heterologous Immunity Adds Another Dimension](https://www.mdpi.com/ijms/ijms-18-01626/article_deploy/html/images/ijms-18-01626-g006.png)
IJMS | Free Full-Text | Unsolved Puzzles Surrounding HCV Immunity: Heterologous Immunity Adds Another Dimension
![Repurposing Old Antibodies for New Diseases by Exploiting Cross Reactivity and Multicolored Nanoparticles | bioRxiv Repurposing Old Antibodies for New Diseases by Exploiting Cross Reactivity and Multicolored Nanoparticles | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2020/03/18/2020.03.17.995738/F1.large.jpg)
Repurposing Old Antibodies for New Diseases by Exploiting Cross Reactivity and Multicolored Nanoparticles | bioRxiv
![Antibodies | Free Full-Text | Understanding and Modulating Antibody Fine Specificity: Lessons from Combinatorial Biology Antibodies | Free Full-Text | Understanding and Modulating Antibody Fine Specificity: Lessons from Combinatorial Biology](https://pub.mdpi-res.com/antibodies/antibodies-11-00048/article_deploy/html/images/antibodies-11-00048-g004.png?1657779540)
Antibodies | Free Full-Text | Understanding and Modulating Antibody Fine Specificity: Lessons from Combinatorial Biology
![PDF] Cross-reactivity in antibody microarrays and multiplexed sandwich assays: shedding light on the dark side of multiplexing. | Semantic Scholar PDF] Cross-reactivity in antibody microarrays and multiplexed sandwich assays: shedding light on the dark side of multiplexing. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/882133a0b4349bc728387004209839f8863d08b5/2-Figure1-1.png)
PDF] Cross-reactivity in antibody microarrays and multiplexed sandwich assays: shedding light on the dark side of multiplexing. | Semantic Scholar
![Frontiers | Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases Frontiers | Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases](https://www.frontiersin.org/files/Articles/617089/fimmu-11-617089-HTML/image_m/fimmu-11-617089-g007.jpg)